Geron (GERN) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

GERN is expected to report earnings to fall 12.60% to -8 cents per share on November 06

Q3'24

Est.

$-0.09

Q2'24

Est.

$-0.10

Q1'24

Beat

by $0.03

Q4'23

Beat

by $0.02

Q3'23

Beat

by $0.02

The last earnings report on August 08 showed earnings per share of -10 cents, beating the estimate of -10 cents. With 9.25M shares outstanding, the current market capitalization sits at 2.75B.

View a ticker or compare two or three

Compare

GERN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For GERN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for GERN (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of therapeutic products for cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

919 East Hillsdale Boulevard

Phone

+1 650 473-7700

Employees

141

Web

https://www.geron.com